Blog
Thoughts on enrollment, precision, and scale.
Featured Resource

Why More Technology Alone Won’t Fix Enrollment
The Limits of Precision in Modern Clinical Trials Introduction: The Technology Paradox Clinical trials have never had access to more advanced technology, yet enrollment has rarely been more challenging. Across therapeutic areas, and particularly in retina, sponsors…
Why More Technology Alone Won’t Fix Enrollment
Clinical trials have never had access to more advanced technology, yet enrollment has rarely been more challenging. Across therapeutic areas, and part…
The Retina Clinical Trial Dilemma: Why Screen Failures Are Rising and What It Means for the Industry
Over 50%. That’s the current screen failure rate across more than 350 active clinical trials in the retina space. Half of all potential participants…
Get Started.
Pick a time that works for you. We’ll discuss your current enrollment challenges, identify where inefficiencies exist, and show you where we can help.
No preparation. No commitment. Just a simple conversation.

